SynthesisDiabetes, obesity & metabolism2026

Injection-site and dermatologic reactions associated with glucagon-like peptide-1 receptor agonists: Insights from meta-analysis of randomised controlled trials and real-world evidence.

Shifa Taj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.